Dr Robin Lindell Stevenson, MD | |
2230 Us Hwy 412, Colcord, OK 74338-4168 | |
(918) 422-5750 | |
(918) 422-4351 |
Full Name | Dr Robin Lindell Stevenson |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 2230 Us Hwy 412, Colcord, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609811801 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 12183 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robin Lindell Stevenson, MD 100 Remington Pl, Tahlequah, OK 74464-4168 Ph: (918) 457-9017 | Dr Robin Lindell Stevenson, MD 2230 Us Hwy 412, Colcord, OK 74338-4168 Ph: (918) 422-5750 |
News Archive
The Medica Research Institute today announced its first three research projects. The projects will be conducted in collaboration with senior investigators from the University of Minnesota School of Public Health.
Illumina, Inc. today announced that, together with Solexa its wholly owned subsidiary, it has filed its initial response to the lawsuit brought by Life Technologies and Applied Biosystems on September 21, 2009 in U.S. District Court in Wilmington, Delaware. In their answer, Illumina and Solexa have denied all of Life's and AB's allegations of patent infringement, and have asserted that AB's licensed patents are invalid.
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers ("BioLife" or the "Company"), today announced that Seattle Business Magazine has included BioLife in its annual list of the 100 best companies to work for in Washington state for 2015.
To unravel the mysterious mechanisms of drug potency for the treatment of cardiac arrhythmias, a group of researchers at UC Davis have developed novel simulations that provide insights on vital atomic-scale drug-cardiac cells interactions.
Researchers at the University of California, San Diego (UCSD) School of Medicine have developed new technology which, combined with proteomics, the large-scale study of the structure and function of proteins and their functions, has allowed them to map an extensive network of the signaling proteins that control cell movement.
› Verified 6 days ago